[Clinical drug research in Denmark--as effective, harmless and cheap as possible].
作者信息
Højgaard L
出版信息
Ugeskr Laeger. 1994 Feb 7;156(6):784-6.
PMID:8016979
Abstract
摘要
相似文献
1
[Clinical drug research in Denmark--as effective, harmless and cheap as possible].
Ugeskr Laeger. 1994 Feb 7;156(6):784-6.
2
A new colonialism?--Conducting clinical trials in India.
N Engl J Med. 2005 Apr 21;352(16):1633-6. doi: 10.1056/NEJMp048361.
3
Cutting the cost of drug development?
Nat Rev Drug Discov. 2004 Apr;3(4):360-4. doi: 10.1038/nrd1347.
4
Clinical research: outlook from industry.
Clin Perform Qual Health Care. 1996 Apr-Jun;4(2):113-4.
5
[The roles and responsibilities of the pharmaceutical industry].
Ugeskr Laeger. 2003 Apr 14;165(16):1676-9.
6
[Pharmaceutical industry and clinical drug research].
Duodecim. 2000;116(24):2813-5.
7
Clinical trials in India: balancing economic opportunity with the public health context.
Natl Med J India. 2006 Mar-Apr;19(2):57-9.
8
America's other drug problem: how the drug industry distorts medicine and politics.
New Repub. 2002 Dec 16;227(25):27-41.
9
Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
CMAJ. 2002 May 14;166(10):1279-80.
10
[Drug development costs are overstated by the industry].
Lakartidningen. 2006;103(9):663-4; discussion 664.
Zotero 插件